EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Decoding Asthma Therapy: The Role of VEGFA and HIF1A in Yanghe Pingchuan Granule's Mechanism

Qiuping Zhang iD, Huizhi Zhu, Yongqi Xia, Chuan Lv

IET Systems Biology · 2026-01 · 20 (1)

DOI: 10.1049/syb2.70067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IET Systems Biology, online erschienen am 13.05.2026. Verfasst von Qiuping Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Anhui University of Chinese Medicine, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Asthma, Hypoxia-Inducible Factor 1, alpha Subunit, Drugs, Chinese Herbal. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Anhui Province Key Laboratory of the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study integrated network pharmacology, bioinformatics, and experimental validation to investigate the glycolysis‐related targets of Yanghe Pingchuan granule (YPG) in asthma therapy. Active ingredients of YPG were screened via TCMSP, with targets identified through UniProt. Asthma‐associated differentially expressed genes (DEGs) were extracted from GEO datasets, whereas asthma‐ and glycolysis‐related targets were mined from GeneCards, OMIM, TTD, DrugBank and MSigDB. Venn analysis identified three key genes (GSTP1, VEGFA and HIF1A) linked to HIF‐1 and VEGF signalling pathways. Molecular docking confirmed strong binding between core YPG compounds (quercetin, kaempferol and luteolin) and these targets. ROC analysis demonstrated high diagnostic value of VEGFA and HIF1A for asthma. In vivo validation showed that YPG significantly downregulated GSTP1, VEGFA and HIF1A expression in asthmatic rats. Our findings establish VEGFA and HIF1A as pivotal glycolysis‐associated targets in asthma, indicating that YPG exerts anti‐asthma effects by modulating these critical regulators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor AAsthmaHypoxia-Inducible Factor 1, alpha SubunitDrugs, Chinese HerbalAnimalsMolecular Docking SimulationRatsHumansGlycolysisSignal TransductionComputational Biology

Stichwörter der Autor:innen

Yanghe Pingchuan Granuleasthmabioinformaticsglycolysisnetwork pharmacology

Substanzen

Vascular Endothelial Growth Factor AHypoxia-Inducible Factor 1, alpha SubunitDrugs, Chinese HerbalHif1a protein, ratvascular endothelial growth factor A, rat

Autor:innen und Institutionen

  • The First Clinical Medical College of Anhui University of Chinese Medicine, Hefei, Anhui, China.
  • Department of Respiratory Medicine, Shuguang Anhui Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Hefei, Anhui, China.
  • Department of Respiratory Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, Anhui, China.

ORCID-Profile: Qiuping Zhang

Förderung

  • Anhui Province Key Laboratory of the Application and Transformation of Traditional Chinese Medicine in the Prevention and Treatment of Major Pulmonary Diseases

Zitieren

APA

Zhang, Q., Zhu, H., Xia, Y., & Lv, C. (2026). Decoding Asthma Therapy: The Role of VEGFA and HIF1A in Yanghe Pingchuan Granule's Mechanism. IET Systems Biology, 20(1). https://doi.org/10.1049/syb2.70067

Vancouver

Zhang Q, Zhu H, Xia Y, Lv C. Decoding Asthma Therapy: The Role of VEGFA and HIF1A in Yanghe Pingchuan Granule's Mechanism. IET Systems Biology. 2026;20(1). doi:10.1049/syb2.70067

BibTeX
@article{Zhang2026,
  author = {Zhang, Qiuping and Zhu, Huizhi and Xia, Yongqi and Lv, Chuan},
  title = {Decoding Asthma Therapy: The Role of VEGFA and HIF1A in Yanghe Pingchuan Granule's Mechanism},
  journal = {IET Systems Biology},
  year = {2026},
  volume = {20},
  number = {1},
  doi = {10.1049/syb2.70067}
}
Kostenlos starten →